Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
3.090
-0.110 (-3.44%)
At close: May 15, 2026, 4:00 PM EDT
2.991
-0.099 (-3.20%)
After-hours: May 15, 2026, 7:58 PM EDT

Cellectar Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.3513.223.299.5619.8735.7
Cash & Short-Term Investments
8.3513.223.299.5619.8735.7
Cash Growth
-39.97%-43.34%143.48%-51.85%-44.36%-37.54%
Other Current Assets
0.920.840.960.890.660.87
Total Current Assets
9.2714.0424.2510.4520.5336.57
Net Property, Plant & Equipment
1.820.911.191.590.980.55
Other Long-Term Assets
0.030.030.030.030.080.08
Total Assets
11.1214.9825.4712.0821.5937.2
Accounts Payable
4.724.427.599.185.483.85
Current Portion of Leases
-0.10.080.060.050.14
Other Current Liabilities
0.150.231.7216.125.97-
Total Current Liabilities
4.874.759.3925.3611.53.99
Long-Term Leases
1.530.310.410.490.550.17
Total Long-Term Liabilities
1.530.310.410.490.550.17
Total Liabilities
6.45.069.825.8512.054.16
Preferred Stock
0.520.520.524.68-1.38
Common Stock
000000
Additional Paid-in Capital
277.6277.15261.12182.92168.14182.56
Retained Earnings
-274.79-269.13-247.34-202.76-159.99-150.9
Total Common Shareholders' Equity
3.348.5414.29-15.168.1533.05
Minority Interest
1.381.381.381.381.38-
Shareholders' Equity
4.729.9215.68-13.789.5433.05
Total Liabilities & Equity
11.1214.9825.4712.0821.5937.2
Total Debt
1.530.410.490.550.60.3
Net Cash (Debt)
6.8212.7922.799.0119.2635.4
Net Cash Growth
-46.68%-43.91%152.94%-53.22%-45.59%-37.61%
Net Cash Per Share
2.084.9018.4122.1281.90191.31
Book Value
3.348.5414.29-15.168.1533.05
Book Value Per Share
1.023.2711.55-37.2134.67178.57
Tangible Book Value
3.348.5414.29-15.168.1533.05
Tangible Book Value Per Share
1.023.2711.55-37.2134.67178.57
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q